NCT06575465

Brief Summary

Background: The Bedouin community in the Negev faces high rates of type 2 diabetes, low treatment adherence, and increased disease complications. Transition to urban living and changing dietary patterns have exacerbated these issues. Current interventions often overlook the potential of culturally tailored approaches leveraging kinship ties and community resources. This study seeks to address these gaps by examining the impact of a family-centered intervention program. Objectives: Primary: Assess the effect of community intervention on Mediterranean diet adherence. Secondary: Evaluate changes in fasting glucose, HbA1c, lipid profiles, BMI, physical activity, and quality of life. Methodology: Study Design: Controlled community intervention trial with two groups (intervention and control). Participants: 170 Bedouin adults diagnosed with overweight, obesity, metabolic syndrome, prediabetes, or type 2 diabetes. Intervention: 10 sessions over 12 months focusing on nutrition, physical activity, and behavioral changes, tailored to cultural norms. Control: Routine care without added intervention. Outcome Measures: Lab tests (HbA1c, lipid profiles), anthropometric measures, Mediterranean diet adherence, physical activity, quality of life, and social belonging. Recruitment and Data Collection: Participants will be recruited via Clalit clinics in Rahat, with the support of local community leaders. Data will be collected through medical records, questionnaires, and physical assessments at baseline, 6, and 12 months. Data Analysis: Statistical analysis will be performed using SAS/SPSS, employing ANOVA, Chi-square tests, and regression models for outcome prediction. Ethical Considerations: Participants' privacy will be ensured through coded data storage. The study will comply with Helsinki guidelines, and participants can withdraw at any time. Conclusion: This study aims to provide culturally tailored interventions to improve health outcomes in the Bedouin community, potentially serving as a model for similar minority groups globally.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Sep 2024May 2026

First Submitted

Initial submission to the registry

August 25, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 28, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

1.3 years

First QC Date

August 25, 2024

Last Update Submit

January 27, 2025

Conditions

Keywords

Type 2 Diabetes MellitusObesityCommunity based participatory researchHealth promotionClinical trialPrediabetes

Outcome Measures

Primary Outcomes (1)

  • To examine the effect of the intervention on the Mediterranean diet score among patients with obesity, metabolic syndrome, prediabetes, and type 2 diabetes over a period of up to one year from their entry into the study

    Examine changes in Mediterranean score using the Mediterranean diet questionnaire (I-MEDAS), the score ranges from 0-17, with a higher value indicating better adherence to the Mediterranean diet pattern.

    Will be examined three times during one year

Secondary Outcomes (11)

  • Fasting blood sugar levels (FPG)

    Three times during a year

  • Levels of glycosylated hemoglobin levels (HBA1c)

    Three times during a year

  • Blood lipid profile (LIPID PROFILE)

    Three times a year

  • Anthropometric measures (weight)

    Three times during a year

  • Anthropometric measures (waist circumference)

    Three times during a year

  • +6 more secondary outcomes

Study Arms (2)

Full Intervention

EXPERIMENTAL

* Will receive a tailored healthy lifestyle intervention program focusing on nutrition, physical activity, and behavioral changes. * Ten sessions will be conducted separately for men and women. * Each session will last for approximately 2 hours. * The program will include educational workshops, cooking demonstrations, physical activity sessions, and group discussions.

Behavioral: Healthy lifestyle nutrition, culture and physical activity workshops

Control group

ACTIVE COMPARATOR

Participants will continue to receive standard care from their healthcare providers without additional intervention.

Other: Usual care

Interventions

The intervention will include monthly sessions in the community setting of physical activity. In addition, monthly nutrition and culture sessions will be held.

Full Intervention

Usual care patients receive in their primary health care

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bedouin men and women aged 18 and above
  • Diagnosed with overweight, obesity, metabolic syndrome, prediabetes, or type 2 diabetes
  • Consent to participate in the study

You may not qualify if:

  • Individuals with other chronic diseases that might interfere with the study
  • Pregnant or lactating women
  • Individuals unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clalit healthcare clinic

Rahat, Israel

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2ObesityPrediabetic State

Interventions

Culture Techniques

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

In Vitro TechniquesInvestigative Techniques

Study Officials

  • Muflah Ataika, MD

    Rahat Counseling Clinic, Southern District, Clalit Health Services.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vered Kaufman-Shriqui, PhD

CONTACT

Maya Maor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Study Design: The study is designed as a controlled community intervention trial. Participants will be divided into two groups: an intervention group and a control group. The intervention group will receive a comprehensive community-based intervention program, while the control group will receive routine care. Intervention Group: * Will receive a tailored healthy lifestyle intervention program focusing on nutrition, physical activity, and behavioral changes. * 10 sessions will be conducted separately for men and women. * Each session will last for approximately 2 hours. * The program will include educational workshops, cooking demonstrations, physical activity sessions, and group discussions. Control Group: • They will continue to receive standard care from their healthcare providers without additional intervention. Duration of the Study: • The study will last for one year, with follow-up assessments conducted at baseline, 6 months, and 12 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 25, 2024

First Posted

August 28, 2024

Study Start

September 1, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

May 31, 2026

Last Updated

January 28, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations